Amaero Provides Update to Financial Guidance, Largely Reaffirming Expectations

(AUST:3DA),(AUST:3DA.AX),(OTC US:AMROF),(Other OTC:AMROF), ~ Revenue to Accelerate in Current Quarter with a Continuation of Growth into FY 2026 ~ ~ Company Expects to be EBITDA Positive in FY 2027 ~ MCDONALD, Tenn., May 28, 2025 (GLOBE NEWSWIRE) — Amaero Ltd (ASX:3DA) (OTCQB: AMROF) (“Amaero” or the “Company”), a leading U.S. domestic producer of high-value C103, […]

Sanuwave Health Appoints Greg Bazar to Board of Directors

(NasdaqGM:SNWV), EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) — Sanuwave Health, Inc. (the “Company” or “Sanuwave”) (Nasdaq:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the addition of Greg Bazar to its Board of Directors. Bazar brings decades of leadership experience in engineering, technology, and cybersecurity to Sanuwave's Board

Financial Institutions, Inc. Announces Quarterly Cash Dividend

(NASDAQ:FISI), WARSAW, N.Y., May 28, 2025 (GLOBE NEWSWIRE) — Financial Institutions, Inc. (Nasdaq: FISI) (the “Company”), parent company of Five Star Bank and Courier Capital, LLC, announced today that its Board of Directors has approved a quarterly cash dividend of $0.31 per outstanding common share. The Company also announced dividends of $0.75 per share on

LPL Financial to Present at the William Blair Growth Stock Conference

(NASDAQ:LPLA), SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) today announced that Matt Audette, President and Chief Financial Officer, will present at the William Blair Growth Stock Conference on June 4. The presentation takes place at 11 a.m. ET. A live audio webcast of the presentation will be accessible at investor.lpl.com,

Nasdaq Executives to Present at Upcoming Investor Conferences

(NASDAQ:NDAQ), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in June with webcasts available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm. Who: Adena Friedman, Chair and CEO, Nasdaq What: Piper Sandler Global Exchange & Trading Conference When: Thursday, June 5, 20252:30 PM ET Who: Tal Cohen,

Silvaco To Present at the Rosenblatt 5th Annual Technology Summit

(NASDAQ:SVCO), SANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) — Silvaco Group, Inc. (Nasdaq: SVCO, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation, today announced that Silvaco's Chief Executive Officer, Dr. Babak Taheri, Interim Chief Financial Officer, Keith Tainsky, and

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

(NASDAQ:ADPT), SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference in Miami,

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

(NASDAQ:CTKB), FREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference in Miami Beach, FL. Cytek management is scheduled to participate in a fireside chat on Wednesday, June 11th

Pool Corporation Announces Upcoming Investor Conference Participation

(NASDAQ:POOL), COVINGTON, La., May 28, 2025 (GLOBE NEWSWIRE) — Pool Corporation (Nasdaq: POOL) announced today that it will participate in the following investor events in the month of June 2025, each consisting of investor meetings and a fireside chat: June 4, 2025 – Stifel Boston Cross Sector 1×1 Conference June 4, 2025 – William Blair

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

(NasdaqGM:ARTV), SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, announced today that management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday,

Scroll to Top